table of content
1 Study Coverage
1.1 Recombinant Protein Drugs Product Introduction
1.2 Global Recombinant Protein Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Recombinant Protein Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Recombinant Protein Drugs Sales in Volume for the Year 2017-2028
1.3 United States Recombinant Protein Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Recombinant Protein Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Recombinant Protein Drugs Sales in Volume for the Year 2017-2028
1.4 Recombinant Protein Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Recombinant Protein Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Recombinant Protein Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Recombinant Protein Drugs Market Dynamics
1.5.1 Recombinant Protein Drugs Industry Trends
1.5.2 Recombinant Protein Drugs Market Drivers
1.5.3 Recombinant Protein Drugs Market Challenges
1.5.4 Recombinant Protein Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Recombinant Protein Drugs Market Segment by Type
2.1.1 Recombinant DNA
2.1.2 Recombinant RNA
2.2 Global Recombinant Protein Drugs Market Size by Type
2.2.1 Global Recombinant Protein Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Recombinant Protein Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Recombinant Protein Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Recombinant Protein Drugs Market Size by Type
2.3.1 United States Recombinant Protein Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Recombinant Protein Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Recombinant Protein Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Recombinant Protein Drugs Market Segment by Application
3.1.1 Pharmaceutical Industry
3.1.2 Others
3.2 Global Recombinant Protein Drugs Market Size by Application
3.2.1 Global Recombinant Protein Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Recombinant Protein Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Recombinant Protein Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Recombinant Protein Drugs Market Size by Application
3.3.1 United States Recombinant Protein Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Recombinant Protein Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Recombinant Protein Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Recombinant Protein Drugs Competitor Landscape by Company
4.1 Global Recombinant Protein Drugs Market Size by Company
4.1.1 Top Global Recombinant Protein Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Recombinant Protein Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Recombinant Protein Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Recombinant Protein Drugs Price by Manufacturer (2017-2022)
4.2 Global Recombinant Protein Drugs Concentration Ratio (CR)
4.2.1 Recombinant Protein Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Protein Drugs in 2021
4.2.3 Global Recombinant Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Recombinant Protein Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Recombinant Protein Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Recombinant Protein Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Recombinant Protein Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Recombinant Protein Drugs Market Size by Company
4.5.1 Top Recombinant Protein Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Recombinant Protein Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Recombinant Protein Drugs Sales by Players (2020, 2021 & 2022)
5 Global Recombinant Protein Drugs Market Size by Region
5.1 Global Recombinant Protein Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Recombinant Protein Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Recombinant Protein Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Recombinant Protein Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Recombinant Protein Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Recombinant Protein Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Recombinant Protein Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Recombinant Protein Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Recombinant Protein Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Recombinant Protein Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Recombinant Protein Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Recombinant Protein Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Recombinant Protein Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporation Information
7.1.2 Novo Nordisk Description and Business Overview
7.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novo Nordisk Recombinant Protein Drugs Products Offered
7.1.5 Novo Nordisk Recent Development
7.2 Amgen
7.2.1 Amgen Corporation Information
7.2.2 Amgen Description and Business Overview
7.2.3 Amgen Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Amgen Recombinant Protein Drugs Products Offered
7.2.5 Amgen Recent Development
7.3 Sanofi
7.3.1 Sanofi Corporation Information
7.3.2 Sanofi Description and Business Overview
7.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Sanofi Recombinant Protein Drugs Products Offered
7.3.5 Sanofi Recent Development
7.4 Eli Lilly
7.4.1 Eli Lilly Corporation Information
7.4.2 Eli Lilly Description and Business Overview
7.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eli Lilly Recombinant Protein Drugs Products Offered
7.4.5 Eli Lilly Recent Development
7.5 Merck Serono
7.5.1 Merck Serono Corporation Information
7.5.2 Merck Serono Description and Business Overview
7.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Merck Serono Recombinant Protein Drugs Products Offered
7.5.5 Merck Serono Recent Development
7.6 Ortho Biotech
7.6.1 Ortho Biotech Corporation Information
7.6.2 Ortho Biotech Description and Business Overview
7.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Ortho Biotech Recombinant Protein Drugs Products Offered
7.6.5 Ortho Biotech Recent Development
7.7 Roche
7.7.1 Roche Corporation Information
7.7.2 Roche Description and Business Overview
7.7.3 Roche Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Roche Recombinant Protein Drugs Products Offered
7.7.5 Roche Recent Development
7.8 Kyowa Hakko Kirin
7.8.1 Kyowa Hakko Kirin Corporation Information
7.8.2 Kyowa Hakko Kirin Description and Business Overview
7.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Kyowa Hakko Kirin Recombinant Protein Drugs Products Offered
7.8.5 Kyowa Hakko Kirin Recent Development
7.9 Pharmingen
7.9.1 Pharmingen Corporation Information
7.9.2 Pharmingen Description and Business Overview
7.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Pharmingen Recombinant Protein Drugs Products Offered
7.9.5 Pharmingen Recent Development
7.10 Abcam
7.10.1 Abcam Corporation Information
7.10.2 Abcam Description and Business Overview
7.10.3 Abcam Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Abcam Recombinant Protein Drugs Products Offered
7.10.5 Abcam Recent Development
7.11 GenSci
7.11.1 GenSci Corporation Information
7.11.2 GenSci Description and Business Overview
7.11.3 GenSci Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 GenSci Recombinant Protein Drugs Products Offered
7.11.5 GenSci Recent Development
7.12 SL PHARM
7.12.1 SL PHARM Corporation Information
7.12.2 SL PHARM Description and Business Overview
7.12.3 SL PHARM Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 SL PHARM Products Offered
7.12.5 SL PHARM Recent Development
7.13 Dongbao Pharm
7.13.1 Dongbao Pharm Corporation Information
7.13.2 Dongbao Pharm Description and Business Overview
7.13.3 Dongbao Pharm Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Dongbao Pharm Products Offered
7.13.5 Dongbao Pharm Recent Development
7.14 Ankebio
7.14.1 Ankebio Corporation Information
7.14.2 Ankebio Description and Business Overview
7.14.3 Ankebio Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Ankebio Products Offered
7.14.5 Ankebio Recent Development
7.15 NCPC
7.15.1 NCPC Corporation Information
7.15.2 NCPC Description and Business Overview
7.15.3 NCPC Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 NCPC Products Offered
7.15.5 NCPC Recent Development
7.16 Heng Rui
7.16.1 Heng Rui Corporation Information
7.16.2 Heng Rui Description and Business Overview
7.16.3 Heng Rui Recombinant Protein Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Heng Rui Products Offered
7.16.5 Heng Rui Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Recombinant Protein Drugs Industry Chain Analysis
8.2 Recombinant Protein Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Recombinant Protein Drugs Distributors
8.3 Recombinant Protein Drugs Production Mode & Process
8.4 Recombinant Protein Drugs Sales and Marketing
8.4.1 Recombinant Protein Drugs Sales Channels
8.4.2 Recombinant Protein Drugs Distributors
8.5 Recombinant Protein Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
